Alimera Sciencesの資本の返還
Alimera Sciencesの資本の返還は何ですか。
Alimera Sciences Inc.の資本の返還は-33.70%です。
資本の返還の定義は何ですか。
株主資本利益率は、株主資本の簿価との関係で事業の収益性の尺度です。これは、会計年度純利益を株主資本合計で除算することによって計算されます。
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
NASDAQのセクタHealth Careにおける資本の返還の企業と比べるAlimera Sciences
Alimera Sciencesは何をしますか。
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Alimera Sciencesと類似の資本の返還
- Papyrus Australiaの資本の返還は-33.74%です。
- Califfi Capitalの資本の返還は-33.74%です。
- Novoheartの資本の返還は-33.74%です。
- SECOSの資本の返還は-33.73%です。
- Coziron Resourcesの資本の返還は-33.73%です。
- Radius Recyclingの資本の返還は-33.71%です。
- Alimera Sciencesの資本の返還は-33.70%です。
- Purple Biotechの資本の返還は-33.70%です。
- Marinus Pharmaceuticalsの資本の返還は-33.68%です。
- Inomin Minesの資本の返還は-33.68%です。
- Yowieの資本の返還は-33.64%です。
- Osprey Gold Developmentの資本の返還は-33.63%です。
- Revolution Bars Plcの資本の返還は-33.63%です。